Advancing gene-modified cell therapies for precision medicine
Ex vivo gene therapy leverages a unique approach to modifying cells outside the body for therapeutic purposes. In this process, cells are extracted from the patient, genetically altered to enhance or change their function, and then reintroduced to treat or cure diseases. A prominent example is CAR-T therapy, where T cells are engineered to target and eliminate cancer cells, paving the way for personalized medicine. We provide a comprehensive suite of tools supporting every step of this journey, from gene editing and vector delivery to cellular re-engineering, supporting you in creating safe, effective and scalable therapies. Revvity provides advanced tools and solutions to support every step of the ex vivo gene therapy process. From viral vector development and nucleic acid quantification to cell isolation and characterization, our technologies enable researchers to efficiently engineer and analyze gene-modified cells for personalized therapies.
For Research Use Only. Not for use in diagnostic procedures.
The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.
